Your browser doesn't support javascript.
loading
Evaluating genetic variants associated with breast cancer risk in high and moderate-penetrance genes in Asians.
Han, Mi-Ryung; Zheng, Wei; Cai, Qiuyin; Gao, Yu-Tang; Zheng, Ying; Bolla, Manjeet K; Michailidou, Kyriaki; Dennis, Joe; Wang, Qin; Dunning, Alison M; Brennan, Paul; Chen, Shou-Tung; Choi, Ji-Yeob; Hartman, Mikael; Ito, Hidemi; Lophatananon, Artitaya; Matsuo, Keitaro; Miao, Hui; Muir, Kenneth; Sangrajrang, Suleeporn; Shen, Chen-Yang; Teo, Soo Hwang; Tseng, Chiu-Chen; Wu, Anna H; Yip, Cheng Har; Kang, Daehee; Xiang, Yong-Bing; Easton, Douglas F; Shu, Xiao-Ou; Long, Jirong.
Afiliação
  • Han MR; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37203,USA.
  • Zheng W; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37203,USA.
  • Cai Q; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37203,USA.
  • Gao YT; Department of Epidemiology, Shanghai Cancer Institute, Shanghai200032, China.
  • Zheng Y; Shanghai Municipal Center for Disease Control and Prevention, Shanghai 200336, China.
  • Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.
  • Michailidou K; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.
  • Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.
  • Wang Q; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.
  • Dunning AM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.
  • Brennan P; International Agency for Research on Cancer, 69372 Lyon CEDEX 08, France.
  • Chen ST; Department of Surgery, Changhua Christian Hospital,Changhua City 50006,Taiwan.
  • Choi JY; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea.
  • Hartman M; Cancer Research Institute, Seoul National University College of Medicine, Seoul 03080, Korea.
  • Ito H; Saw Swee Hock School of Public Health, National University of Singapore, Singapore 117549, Singapore.
  • Lophatananon A; Department of Surgery, National University Health System, Singapore 119228, Singapore.
  • Matsuo K; Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya 464-8681, Japan.
  • Miao H; Division of Health Sciences, Warwick Medical School, Warwick University, Coventry CV4 7AL, UK.
  • Muir K; Division of Molecular Medicine, Aichi Cancer CenterResearch Institute, Nagoya 464-8681, Japan.
  • Sangrajrang S; Department of Epidemiology, Nagoya University Graduates School of Medicine, Nagoya 466-8550, Japan.
  • Shen CY; Saw Swee Hock School of Public Health, National University of Singapore, Singapore 117549, Singapore.
  • Teo SH; Division of Health Sciences, Warwick Medical School, Warwick University, Coventry CV4 7AL, UK.
  • Tseng CC; Institute of Population Health, University of Manchester, Manchester M13 9PL, UK.
  • Wu AH; National Cancer Institute,Bangkok 10400, Thailand.
  • Yip CH; Taiwan Biobank, Institute of Biomedical Sciences, Academia Sinica, Taipei 11529, Taiwan.
  • Kang D; School of Public Health, China Medical University, Taichong 40402, Taiwan.
  • Xiang YB; Cancer Research Initiatives Foundation, Subang Jaya, Selangor 47500, Malaysia.
  • Easton DF; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles CA 90032, USA.
  • Shu XO; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles CA 90032, USA.
  • Long J; Breast Cancer Research Unit, Cancer Research Institute, University Malaya Medical Centre, Kuala Lumpur 59100, Malaysia and.
Carcinogenesis ; 38(5): 511-518, 2017 05 01.
Article em En | MEDLINE | ID: mdl-28419251
ABSTRACT
Over the past 20 years, high-penetrance pathogenic mutations in genes BRCA1, BRCA2, TP53, PTEN, STK11 and CDH1 and moderate-penetrance mutations in genes CHEK2, ATM, BRIP1, PALB2, RAD51C, RAD50 and NBN have been identified for breast cancer. In this study, we investigated whether there are additional variants in these 13 genes associated with breast cancer among women of Asian ancestry. We analyzed up to 654 single nucleotide polymorphisms (SNPs) from 6269 cases and 6624 controls of Asian descent included in the Breast Cancer Association Consortium (BCAC), and up to 236 SNPs from 5794 cases and 5529 controls included in the Shanghai Breast Cancer Genetics Study (SBCGS). We found three missense variants with minor allele frequency (MAF) <0.05 rs80358978 (Gly2508Ser), rs80359065 (Lys2729Asn) and rs11571653 (Met784Val) in the BRCA2 gene, showing statistically significant associations with breast cancer risk, with P-values of 1.2 × 10-4, 1.0 × 10-3 and 5.0 × 10-3, respectively. In addition, we found four low-frequency variants (rs8176085, rs799923, rs8176173 and rs8176258) in the BRCA1 gene, one common variant in the CHEK2 gene (rs9620817), and one common variant in the PALB2 gene (rs13330119) associated with breast cancer risk at P < 0.01. Our study identified several new risk variants in BRCA1, BRCA2, CHEK2, and PALB2 genes in relation to breast cancer risk in Asian women. These results provide further insights that, in addition to the high/moderate penetrance mutations, other low-penetrance variants in these genes may also contribute to breast cancer risk.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Variação Genética / Neoplasias da Mama / Penetrância / Predisposição Genética para Doença / Povo Asiático Tipo de estudo: Etiology_studies / Screening_studies Limite: Female / Humans Idioma: En Revista: Carcinogenesis Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Variação Genética / Neoplasias da Mama / Penetrância / Predisposição Genética para Doença / Povo Asiático Tipo de estudo: Etiology_studies / Screening_studies Limite: Female / Humans Idioma: En Revista: Carcinogenesis Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos